Ventral striatal dopamine reflects behavioral and neural signatures of model-based control during sequential decision making

• Whether humans make choices based on a deliberative “model-based” or a reflexive “model-free” system of behavioral control remains an ongoing topic of research. Dopamine is implicated in motivational drive as well as in planning future actions. Here, we demonstrate that higher presynaptic dopamine in human ventral striatum is associated with more pronounced model-based behavioral control, as well as an enhanced coding of model-based signatures in lateral prefrontal cortex and diminished coding of model-free learning signals in ventral striatum. Our study links ventral striatal presynaptic dopamine to a balance between two distinct modes of behavioral control in humans. The findings have implications for neuropsychiatric diseases associated with alterations of dopamine neurotransmission and a disrupted balance of behavioral control.Dual system theories suggest that behavioral control is parsed between a deliberative “model-based” and a more reflexive “model-free” system. A balance of control exerted by these systems is thought to be related to dopamine neurotransmission. However, in the absence of direct measures of human dopamine, it remains unknown whether this reflects a quantitative relation with dopamine either in the striatum or other brain areas. Using a sequential decision task performed during functional magnetic resonance imaging, combined with striatal measures of dopamine using [18F]DOPA positron emission tomography, we show that higher presynaptic ventral striatal dopamine levels were associated with a behavioral bias toward more model-based control. Higher presynaptic dopamine in ventral striatum was associated with greater coding of model-based signatures in lateral prefrontal cortex and diminished coding of model-free prediction errors in ventral striatum. Thus, interindividual variability in ventral striatal presynaptic dopamine reflects a balance in the behavioral expression and the neural signatures of model-free and model-based control. Our data provide a novel perspective on how alterations in presynaptic dopamine levels might be accompanied by a disruption of behavioral control as observed in aging or neuropsychiatric diseases such as schizophrenia and addiction.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)